# Halitosis Treatment Market

> Halitosis Treatment Market Research Report Information By Indication (Respiratory, Liver, Kidney, Gastrointestinal, Systemic, and Others), By Diagnostic Tests (Halimeter, Gas Chromatography, BANA Test, Β-Galactosidase Activity Assay, and Others), By Drug Treatment (Antacids, Antiseptics, Ranitidine, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 10.52%
- **2024:** $ 4.89 Billion
- **2025:** $ 5.4 Billion
- **2035:** $ 14.7 Billion
- **Key Players:** Colgate-Palmolive (US), Procter & Gamble (US), Unilever (GB), Johnson & Johnson (US), GlaxoSmithKline (GB), Church & Dwight (US), Henkel (DE), Listerine (US), Oral-B (US)

**Report ID:** MRFR/Pharma/2493-CR · **Pages:** 153 · **Author:** Vikita Thakur & Kinjoll Dey · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/halitosis-treatment-market-3758

---

## Market Summary

## **Global Halitosis Treatment Market Overview**

The Halitosis Treatment Market Size was valued at USD 4.37 Billion in 2023 and is projected to grow from USD 4.89 Billion in 2024 to USD 10.91 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.52% during the forecast period (2024 - 2032).The market is expanding because to the ageing population as well as concerns about chronic diseases such diabetes, liver disease, lungs disease, and liver failure are the key market drivers enhancing the market growth. 

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review **In 2021,**

the North American market saw the introduction of environmentally friendly and sustainable dental care products by Hello Products, which is a unit owned by Colgate Company. For instance, it released toothbrush that can be reused, mint oil plus coconut oil floss thread, breath freshening lozenges as well as mouthwashes.

**It was on November 2021**

when Church & Dwight Co., Inc. disclosed that it had signed an agreement to buy TheraBreath brand. TheraBreath is America’s second-largest-selling alcohol-free mouthwash brand. This action will stimulate demand due to these tendencies in North American markets.

SmartMouth launched SmartMouth Mouth Sore Oral Rinse, its latest revolution in dental healthcare, sometime around May 2022. While it will still help you keep your breath fresh all day long with only two rinses daily as per the old SmartMouth formulae, this new version is meant to counteract sudden pain inside our mouths, too.

TheraBreath introduced a new product called “TheraBreath Fresh Breath Oral Rinse with Zinc” in October last year. It contains zinc gluconate, which is essentially an element whose job is to eliminate bacteria that cause bad breath, thereby limiting plaque build-up and tartar formation on teeth. Additionally, the product is gluten-free, vegan, alcohol-free, certified Kosher, and includes xylitol as a natural sweetener to avoid mouth dryness or tooth decay if it contains other sugars.

**Colgate-Palmolive announced in September 2022**

that it has signed an agreement to purchase Hello Products LLC (Hello), which is one of the top global names in oral care products. The fast-growing brand makes eco-friendly options for items like toothpaste, floss, and mouthwash brushes, among others. This will enable Colgate to reinforce its high-end image within the oral care sector whilst incorporating more creative and sustainable products into its range.

**Halitosis Treatment Market Trends**

Market CAGR for halitosis treatment is being driven by the rising treatment. Further factors driving the market's expansion include the increased incidence of periodontal disorders, rising alcohol and tobacco usage, tonsillitis, and inflammation of the nose, throat, and sinuses. Halitosis is believed to be the third most prevalent cause for seeing a dentist, after periodontal disease and dental caries, according to a study titled "The Prevalence and Determinant Factors of Oral Halitosis in Northwest Ethiopia: A Cross-Sectional Study" released by Dovepress in 2021. Between 22% and 50% of individuals worldwide reported having halitosis.

Between 22% and 50% of individuals worldwide reported having halitosis. In addition, according to another article titled "Say Ahhh: Experience and Views on Halitosis Management in the General Public in Victoria, Australia," published in August 2021 by the International Dental Journal, 8% to 10% of cases of halitosis are caused by extraoral factors, while up to 90% are caused by intraoral sources, such as tongue coating or periodontitis. Without any intraoral causes of halitosis, a patient may suffer from systemic, metabolic, or genetic diseases.

As a result, a key element anticipated to influence halitosis diagnosis and therapy shortly is the rising incidence of the condition worldwide.

Additionally, gum (periodontal) disease, closely related to halitosis, may show warning signs such as chronic foul breath or an unpleasant taste in the mouth. The prevalence of total periodontitis and stage III/IV periodontitis was 85.4% and 48.5%, respectively, according to a study titled "Periodontal Disease Prevalence, Extent, and Risk Associations in Untreated Individuals" that was released in January 2022 by the AAP and the EFP. 78.4% and 31.1%, respectively, of people had moderate-to-severe periodontitis, according to the CDC/AAP. Therefore, it is anticipated that the rising frequency of periodontal disorders will propel market expansion during the study period.

Halitosis is a widespread problem worldwide where severe instances only affect 5% of the population, but intermediate cases are common. The market is growing as the number of persons with halitosis increases and public knowledge of the condition and its treatment increases. In the US, almost 80 million people spend more than USD 10.75 billion yearly on dental care items. Thus, driving the Halitosis Treatment market revenue.

## **Halitosis Treatment Market Segment Insights**

### **Halitosis Treatment Indication Insights**

Based on indication, the Halitosis Treatment market segmentation includes respiratory, liver, kidney,

[gastrointestinal,](../../../reports/gastrointestinal-drugs-market-558)

systemic, and others. The liver segment dominated the market, accounting for 35% of market revenue. Trimethylamine is more prevalent in cirrhotic patients, which leads to bad breath. One of the odd symptoms of fatty liver disease is "breath of the dead." The Fetor hepaticus, often known as the breath of the dead, is a lingering odor that differs from typical breath. Hepatitis and liver failure are intimately connected to fetor hepaticus. 

Organ-related bad breath is typically caused by a sickness or food that interacts with blood levels and generates an odor. Since liver illnesses and bad breath are frequently linked, the rise in liver diseases is anticipated to accelerate the segment's growth throughout the projected period.

### **Halitosis Treatment Diagnostic Tests Insights**

Based on diagnostic tests, the Halitosis Treatment market segmentation includes an altimeter, gas

[chromatography](../../../reports/chromatography-systems-market-2324)

, BANA test, and Β-galactosidase activity assay. The BANA test segment dominated the market. The BANA test assesses the proteolytic activity of certain oral anaerobes that contribute to oral malodor. It refers to the enzymatic breakdown of [N-benzoyl-dL-arginine-2-napthylamide]. Treponema denticola, Prophyromona gingivitis, and Bacteroides forsythias (Red complex) are a few bacteria that create waste products that are highly odiferous and, as a result, contribute to foul breath. The N-benzoyl enzyme is destroyed when a patient's saliva sample containing these bacteria is added to the BANA testing chemical. The test substance changes color due to this biodegradation, indicating a successful response.

### **Halitosis Treatment Drug Treatment Insights**

The Halitosis Treatment market segmentation, based on Drug Treatment, includes antacids, antiseptics, ranitidine, and others. The antacids generated the most income. Antacids are frequently used since they are affordable and help to reduce the discomfort, irritation, edema, and inflammation brought on by heartburn. Additionally, several product advancements, such as creating powerful and safe raft-forming antacids that offer improved efficacy and a longer duration of action, are boosting the market's expansion. The market is expected to develop due to the increasing use of chewable tablets in various flavors that are convenient to store, deliver the right dosage, and enhance patient adherence.

**Figure 1: Halitosis Treatment Market, by Drug Treatment, 2022 & 2032 (USD Billion)**

_Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review_

### **Halitosis Treatment Regional Insights**

By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American Halitosis Treatment market area will dominate this market due to an increase in periodontal disorders, a rise in halitosis prevalence, and increased general knowledge of the condition and its treatment options.

Further, the major countries studied in the market report are The US, Canada, the UK, Italy, Spain, China, Japan, India, German, France, Australia, South Korea, and Brazil.

**Figure 2: HALITOSIS TREATMENT MARKET SHARE BY REGION 2022 (USD Billion)**

_Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review_

Europe has the second-largest market share for Halitosis Treatment. Due to rising oral hygiene awareness among people and rising diagnostic and therapeutic options for treating foul breath in several regional nations, the increasing prevalence of chronic illnesses like diabetes, respiratory conditions, and renal or liver failure with the growing population. Growing older adults with various conditions also contribute to the market's expansion. Furthermore, the German Halitosis Treatment market dominated, while the UK Halitosis Treatment market grew fastest in Europe.

From 2023 to 2032, the Asia-Pacific Halitosis Treatment Market will develop at the quickest CAGR. A rise in knowledge about halitosis and the treatments available to cure it. Additionally, rising consumer desire for novel dental care products impacts market expansion. The region's residents make significant financial investments in healthcare, particularly dental care. Future growth of the market is predicted. Furthermore, China's Halitosis Treatment market had the highest market share, whereas India's Halitosis Treatment market was the Asia-Pacific region's fastest growing.

**Halitosis Treatment Key Market Players & Competitive Insights**

Leading market companies are extensively spending R&D on increasing their product lines, which will help the Halitosis Treatment market grow even more. Important market developments include new product releases, acquisitions and mergers, contractual agreements, greater investments, and collaboration with other organizations. The Halitosis Treatment industry must produce cost-effective merchandise to flourish and thrive in a more competitive and increasing market climate.

Manufacturing locally to reduce operating costs is an effective business strategy manufacturers use in the worldwide Halitosis Treatment industry to serve clients and expand the market sector. The Halitosis Treatment industry has provided some of the most important benefits recently. Church & Dwight., Colgate-Palmolive, and other major companies in the Halitosis Treatment market are aiming to enhance market demand by investing in research and development activities

American consumer goods corporation Colgate-Palmolive has its main office on Park Avenue in Midtown Manhattan, New York City. Production, distribution, and provision of domestic, health, personal care, and veterinary items are the company's areas of expertise. The biggest manufacturer of soap and detergent in the world, Procter & Gamble (P&G), has long been a rival of Colgate-Palmolive. Following World War II, P&G launched their Tide laundry detergent, which attracted thousands of customers away from Colgate's soaps. When P&G introduced fluoride to their toothpaste, Colgate lost its top spot in the market (Colgate has subsequently reclaimed the top sales spot).

In May 2021, In the United States, Colgate's Hello Products debuted fresh, natural, and eco-friendly oral care items like a reusable toothbrush, floss flavored with peppermint oil and coconut oil, tablets that freshen breath, and mouthwashes.

The market leader in home and personal care goods is Church & Dwight. ARM & HAMMER, Batiste, OxiClean, Trojan, XTRA, Nair, First Response, Spinbrush, Orajel, vita fusion, Li'l Critters, Water Pik, FLAWLESS, Zicam, and TheraBreath are just a few of our internationally recognized brands. They were established in 1846, operate internationally, and are included in the S&P 500. At Church & Dwight, they fuel people's daily lives by offering high-quality, cost-effective consumer goods. Where impact meets ambition is here. They are proud to be experts in our fields. Their team of highly skilled individuals innovates and concentrates on innovative methods.

In November 2021, Church & Dwight Co., Inc. signed a legally binding contract to buy the TheraBreath name. TheraBreath is the second most popular brand of alcohol-free mouthwash in the US. Therefore, these advancements will probably help the market in North America flourish.

**Key Companies in the Halitosis Treatment market include**

### Halitosis Treatment Market Industry Developments

- **Q2 2024: TheraBreath Launches New Oral Rinse Targeting Halitosis** TheraBreath announced the launch of a new oral rinse specifically formulated to target halitosis, expanding its product portfolio in the oral care market.
- **Q2 2024: GSK Introduces Sensodyne Fresh Breath Toothpaste for Halitosis Relief** GlaxoSmithKline launched Sensodyne Fresh Breath Toothpaste, designed to address halitosis while providing sensitivity relief, marking a new addition to its oral health product line.
- **Q3 2024: Oral Science Announces Partnership with Dental Clinics for Halitosis Treatment Program** Oral Science entered into a partnership with a network of dental clinics to implement a specialized halitosis treatment program using its proprietary products.
- **Q3 2024: Colgate-Palmolive Expands Manufacturing Facility for Halitosis Treatment Products** Colgate-Palmolive announced the expansion of its manufacturing facility in New Jersey to increase production capacity for its halitosis treatment product line.
- **Q4 2024: FDA Approves New Prescription Mouthwash for Chronic Halitosis** The U.S. FDA approved a new prescription mouthwash developed for chronic halitosis, marking a regulatory milestone for advanced oral care therapeutics.
- **Q4 2024: Johnson & Johnson Acquires BreathRx Brand to Strengthen Halitosis Portfolio** Johnson & Johnson completed the acquisition of the BreathRx brand, enhancing its portfolio of products targeting halitosis and oral malodor.
- **Q1 2025: LISTERINE Launches Advanced Formula for Bad Breath in Asia-Pacific** LISTERINE introduced an advanced mouthwash formula targeting bad breath in the Asia-Pacific region, aiming to capture growing demand for halitosis solutions.
- **Q1 2025: Oral Care Startup BreathWell Raises $15M Series A to Develop Halitosis Diagnostic Device** BreathWell, a health tech startup, secured $15 million in Series A funding to accelerate development of its non-invasive halitosis diagnostic device.
- **Q2 2025: Procter & Gamble Announces Strategic Partnership with Dental Chain for Halitosis Education** Procter & Gamble formed a strategic partnership with a major dental chain to launch a halitosis education and treatment initiative across multiple clinics.
- **Q2 2025: FreshBreath Technologies Files for IPO to Fund Halitosis Treatment Product Expansion** FreshBreath Technologies filed for an initial public offering, aiming to raise capital for expanding its halitosis treatment product line and global distribution.
- **Q3 2025: Dentek Unveils New Tongue Cleaner for Halitosis Prevention** Dentek launched a new tongue cleaner designed to help prevent halitosis, broadening its oral hygiene product offerings.
- **Q3 2025: Novartis Receives European Approval for Halitosis Treatment Tablet** Novartis received regulatory approval in Europe for its new tablet indicated for the treatment of halitosis, expanding its presence in the oral care therapeutics market.

## **Halitosis Treatment Market Segmentation**

### **Halitosis Treatment Indication Outlook**

### **Halitosis Treatment Diagnostic Tests Outlook**

### **Halitosis Treatment Drug Treatment Outlook**

### **Halitosis Treatment Regional Outlook**

## Market Drivers

### Rising Incidence of Halitosis

The rising incidence of halitosis is a critical driver for the Halitosis Treatment Market. Factors such as poor dietary habits, smoking, and certain medical conditions have contributed to an increase in the prevalence of bad breath among the population. Research indicates that approximately 25% of adults experience halitosis at some point in their lives, creating a substantial market for treatment options. This growing incidence is prompting consumers to seek effective solutions, thereby driving demand for products such as mouthwashes, chewing gums, and breath sprays. Consequently, the Halitosis Treatment Market is likely to witness robust growth as it responds to the needs of an expanding consumer base.

### Expansion of E-commerce Platforms

The expansion of e-commerce platforms is transforming the Halitosis Treatment Market. With the increasing reliance on online shopping, consumers are now able to access a wider range of halitosis treatment products from the comfort of their homes. This shift has been accelerated by the convenience and accessibility that e-commerce offers, allowing consumers to compare products and read reviews before making a purchase. Market data shows that online sales of oral care products have surged by 30% in recent years. As a result, manufacturers are increasingly focusing on their online presence and digital marketing strategies to capture this growing segment of the market, thereby enhancing the overall growth potential of the Halitosis Treatment Market.

### Increasing Awareness of Oral Hygiene

The rising awareness regarding oral hygiene is a pivotal driver for the Halitosis Treatment Market. As individuals become more informed about the implications of poor oral health, the demand for effective halitosis treatments is likely to surge. Educational campaigns and initiatives by dental associations have contributed to this heightened awareness, emphasizing the importance of regular dental check-ups and proper oral care. This trend is reflected in market data, which indicates a steady increase in the sales of mouthwashes and breath fresheners, projected to reach USD 2 billion by 2026. Consequently, the Halitosis Treatment Market is expected to benefit from this growing consumer consciousness, leading to an expansion in product offerings and innovations.

### Technological Advancements in Dental Care

Technological advancements in dental care are significantly influencing the Halitosis Treatment Market. Innovations such as smart toothbrushes, mobile applications for oral health tracking, and advanced diagnostic tools are enhancing the effectiveness of halitosis treatments. These technologies not only improve the accuracy of diagnosing halitosis but also facilitate personalized treatment plans for patients. Market data suggests that the integration of technology in dental care has led to a 15% increase in the adoption of oral health products. As consumers increasingly seek out technologically advanced solutions, the Halitosis Treatment Market is poised for growth, with manufacturers investing in research and development to create cutting-edge products.

### Growing Demand for Natural and Organic Products

The growing demand for natural and organic products is reshaping the Halitosis Treatment Market. Consumers are increasingly gravitating towards products that are free from synthetic chemicals and artificial additives. This trend is driven by a broader movement towards health and wellness, where individuals prioritize natural ingredients for their oral care routines. Market data indicates that the organic oral care segment is expected to grow at a CAGR of 10% over the next five years. As a result, manufacturers are reformulating their products to include natural ingredients such as essential oils and herbal extracts, thereby catering to the evolving preferences of consumers in the Halitosis Treatment Market.

## Future Outlook

The Halitosis Treatment Market is projected to grow at a 10.52% CAGR from 2025 to 2035, driven by increasing awareness and innovative treatment options.

**New opportunities:**

- Development of personalized oral care products Expansion of telehealth consultations for halitosis Integration of AI-driven diagnostics in dental practices

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

## Segment Insights

### By Indication: Gastrointestinal (Largest) vs. Respiratory (Fastest-Growing)

The Halitosis Treatment Market exhibits a varied distribution of segment values, with the Gastrointestinal segment emerging as the largest contributor. This segment encompasses a wide range of conditions affecting digestion and oral health, strongly influencing breath odor. Following closely, the Respiratory segment is gaining traction, tapping into increasing awareness of conditions related to oral and nasal health that affect halitosis. As consumer understanding of halitosis deepens, the distribution of market shares among these segments continues to evolve. The growth trends in the Indication segment are particularly promising for the Respiratory category, which is recognized as the fastest-growing area in the Halitosis Treatment Market. Factors contributing to this growth include rising incidences of respiratory infections, increased focus on oral hygiene, and advancements in treatment solutions specific to breath-related issues. Meanwhile, the Gastrointestinal segment maintains its position through persistent demand for comprehensive treatment options catering to digestive health and its direct correlation to oral malodor, ensuring steady market relevance for these treatments.

Gastrointestinal (Dominant) vs. Respiratory (Emerging)

The Gastrointestinal segment remains the dominant force within the Halitosis Treatment Market, primarily attributed to the close links between digestive health and oral hygiene. Conditions such as acid reflux and gastrointestinal infections significantly impact halitosis, making treatments focused on this area essential. This segment is characterized by a wide range of treatment options, including [dietary supplements](https://www.marketresearchfuture.com/reports/dietary-supplements-market-1134), probiotics, and therapeutic medications, catering to varied consumer needs. In contrast, the Respiratory segment is marked as the emerging category, rapidly gaining traction due to the increasing recognition of the implications of respiratory conditions such as sinusitis and allergies on halitosis. Despite being smaller in market share, the emergence of innovative treatment solutions and heightened consumer awareness bolster its growth, positioning it as a significant area for future development.

### By Diagnostic Tests: Halimeter (Largest) vs. Gas Chromatography (Fastest-Growing)

The Halitosis Treatment Market is primarily segmented based on various diagnostic tests. Halimeter holds the largest market share as it has become the standard diagnostic device used for measuring sulfur compounds in breath, a key indicator of halitosis. Following Halimeter, [Gas Chromatography](https://www.marketresearchfuture.com/reports/gas-chromatography-market-31118) is rapidly gaining popularity, especially in research settings, due to its extensive accuracy and sensitivity in detecting a broader range of volatile compounds relevant to halitosis. The BANA Test and Β-Galactosidase Activity Assay also contribute to this segment but have not reached the prominence of the former two testing methods. Growth trends in the Diagnostic Tests segment are driven by increasing awareness of oral hygiene and the rising prevalence of halitosis among the population. As technology advances, more precise and user-friendly testing options are emerging, enhancing accessibility for both patients and clinicians. The rising demand for rapid and accurate diagnosis continues to favor Gas Chromatography as the fastest-growing option in the segment, reflecting a broader trend toward sophisticated diagnostic tools in healthcare.

Halimeter (Dominant) vs. BANA Test (Emerging)

Halimeter is recognized as the dominant diagnostic tool in the Halitosis Treatment Market due to its reliability and ease of use. It is widely adopted in clinical settings for its ability to provide immediate results, assisting healthcare professionals in making prompt diagnostic decisions regarding halitosis. On the other hand, the BANA Test, while gaining traction for its specificity in bacterial identification contributing to halitosis, remains an emerging alternative. Its market appeal lies in its straightforward approach and the ability to pinpoint specific bacterial activity, which is critical for targeted treatment. The continued development of these diagnostic methods is instrumental in refining halitosis management and improving patient outcomes.

### By Drug Treatment: Antacids (Largest) vs. Antiseptics (Fastest-Growing)

The Halitosis Treatment Market displays a rich diversity of drug treatment options, with antacids holding the largest share among the segments. Their longstanding efficacy in neutralizing stomach acid impacts bad breath positively, making them a preferred choice for many consumers. In comparison, antiseptics have carved a niche as an increasingly popular alternative, driven by their dual action of eliminating oral bacteria and providing fresh breath. Their acceptance is growing as consumers seek more holistic approaches to managing halitosis. Market trends indicate that the use of antiseptics is surging due to rising consumer awareness about oral health and hygiene. Factors such as increased adoption of preventive healthcare practices and innovations in antiseptic formulation are propelling their growth. As consumers become more inclined towards quick and effective solutions for bad breath, this segment's dynamics are swiftly transforming, marking it as a significant player in the market.

Antacids (Dominant) vs. Antiseptics (Emerging)

Antacids have traditionally dominated the Halitosis Treatment Market due to their established role in neutralizing acidity that leads to bad breath. They are well-accepted within households and easily accessible, contributing to their sustained popularity. On the other hand, antiseptics are emerging as formidable competitors in this space, appealing particularly to health-conscious consumers. Their ability to target bacterial growth directly, combined with attractive packaging and marketing strategies, enhances their visibility. The rising trend of integrating natural and organic components into antiseptic formulations further boosts their market potential. This dynamic interplay between the established presence of antacids and the escalating appeal of antiseptics sets a compelling stage for evolution in the halitosis treatment landscape.

## Regional Market Share Analysis

### North America : Market Leader in Halitosis Treatment Market

North America is the largest market for halitosis treatment, accounting for approximately 40% of the global share. The region's growth is driven by increasing awareness of oral hygiene, rising disposable incomes, and a growing aging population. Regulatory support from health organizations promoting oral health initiatives further catalyzes market expansion. The demand for innovative products, including mouthwashes and breath fresheners, is on the rise, reflecting changing consumer preferences. The competitive landscape in North America is robust, with key players like Colgate-Palmolive, Procter & Gamble, and Johnson & Johnson leading the market. These companies invest heavily in research and development to introduce new products that cater to consumer needs. The presence of established brands and a strong distribution network enhances market accessibility, ensuring that consumers have a wide range of options for halitosis treatment.

### Europe : Emerging Market with Growth Potential

Europe is witnessing significant growth in the halitosis treatment market, holding approximately 30% of the global share. Factors such as increasing health consciousness, a rise in dental care awareness, and the influence of social media on personal grooming are driving demand. Regulatory bodies in Europe are also emphasizing the importance of oral health, which is expected to further boost market growth. The region's diverse population and varying consumer preferences create opportunities for tailored products. Leading countries in Europe include Germany, the UK, and France, where the presence of major players like Unilever and GlaxoSmithKline is notable. The competitive landscape is characterized by a mix of established brands and emerging companies focusing on innovative solutions. The market is also seeing a trend towards natural and organic products, reflecting changing consumer preferences towards healthier options.

### Asia-Pacific : Rapidly Growing Market Segment

Asia-Pacific is rapidly emerging as a significant market for halitosis treatment, accounting for approximately 25% of the global share. The growth is driven by increasing urbanization, rising disposable incomes, and a growing awareness of oral hygiene among consumers. Countries like China and India are witnessing a surge in demand for oral care products, supported by government initiatives promoting dental health. The region's diverse demographics also contribute to varied product preferences, enhancing market potential. Key players in the Asia-Pacific market include Colgate-Palmolive and Procter & Gamble, which are expanding their product lines to cater to local tastes. The competitive landscape is evolving, with both multinational corporations and local brands vying for market share. The increasing penetration of e-commerce platforms is also facilitating access to a wider range of halitosis treatment options for consumers in this region.

### Middle East and Africa : Untapped Market with Opportunities

The Middle East and Africa region represents an untapped market for halitosis treatment, holding approximately 5% of the global share. The growth potential is significant, driven by increasing urbanization, rising disposable incomes, and a growing awareness of oral health. Regulatory initiatives aimed at improving healthcare access and promoting oral hygiene are expected to catalyze market growth. The region's diverse cultures and lifestyles also create opportunities for tailored products that meet specific consumer needs. Leading countries in this region include South Africa and the UAE, where the presence of key players like Henkel and Church & Dwight is notable. The competitive landscape is characterized by a mix of local and international brands, with a focus on affordability and accessibility. As awareness of halitosis treatment options increases, the market is poised for substantial growth in the coming years.

## Competitive Benchmarking

Leading market companies are extensively spending R&D on increasing their product lines, which will help the Halitosis Treatment Market grow even more. Important market developments include new product releases, acquisitions and mergers, contractual agreements, greater investments, and collaboration with other organizations. The Halitosis Treatment industry must produce cost-effective merchandise to flourish and thrive in a more competitive and increasing market climate. Manufacturing locally to reduce operating costs is an effective business strategy manufacturers use in the worldwide Halitosis Treatment industry to serve clients and expand the market sector. The Halitosis Treatment industry has provided some of the most important benefits recently. Church & Dwight., Colgate-Palmolive, and other major companies in the Halitosis Treatment Market are aiming to enhance market demand by investing in research and development activities American consumer goods corporation Colgate-Palmolive has its main office on Park Avenue in Midtown Manhattan, New York City. Production, distribution, and provision of domestic, health, personal care, and veterinary items are the company's areas of expertise. The biggest manufacturer of soap and detergent in the world, Procter & Gamble (P&G), has long been a rival of Colgate-Palmolive. Following World War II, P&G launched their Tide laundry detergent, which attracted thousands of customers away from Colgate's soaps. When P&G introduced fluoride to their toothpaste, Colgate lost its top spot in the market (Colgate has subsequently reclaimed the top sales spot). In May 2021, In the United States, Colgate's Hello Products debuted fresh, natural, and eco-friendly oral care items like a reusable toothbrush, floss flavored with peppermint oil and coconut oil, tablets that freshen breath, and mouthwashes. The market leader in home and personal care goods is Church & Dwight. ARM & HAMMER, Batiste, OxiClean, Trojan, XTRA, Nair, First Response, Spinbrush, Orajel, vita fusion, Li'l Critters, Water Pik, FLAWLESS, Zicam, and TheraBreath are just a few of our internationally recognized brands. They were established in 1846, operate internationally, and are included in the S&P 500. At Church & Dwight, they fuel people's daily lives by offering high-quality, cost-effective consumer goods. Where impact meets ambition is here. They are proud to be experts in our fields. Their team of highly skilled individuals innovates and concentrates on innovative methods. In November 2021, Church & Dwight Co., Inc. signed a legally binding contract to buy the TheraBreath name. TheraBreath is the second most popular brand of alcohol-free mouthwash in the US. Therefore, these advancements will probably help the market in North America flourish.

## Recent News & Developments

- **Q2 2024: TheraBreath Launches New Oral Rinse Targeting Halitosis** TheraBreath announced the launch of a new [oral rinse](https://www.marketresearchfuture.com/reports/oral-rinse-market-25239) specifically formulated to target halitosis, expanding its product portfolio in the oral care market.
- **Q2 2024: GSK Introduces Sensodyne Fresh Breath Toothpaste for Halitosis Relief** GlaxoSmithKline launched Sensodyne Fresh Breath Toothpaste, designed to address halitosis while providing sensitivity relief, marking a new addition to its oral health product line.
- **Q3 2024: Oral Science Announces Partnership with Dental Clinics for Halitosis Treatment Market Program** Oral Science entered into a partnership with a network of dental clinics to implement a specialized halitosis treatment program using its proprietary products.
- **Q3 2024: Colgate-Palmolive Expands Manufacturing Facility for Halitosis Treatment Market Products** Colgate-Palmolive announced the expansion of its manufacturing facility in New Jersey to increase production capacity for its halitosis treatment product line.
- **Q4 2024: FDA Approves New Prescription Mouthwash for Chronic Halitosis** The U.S. FDA approved a new prescription mouthwash developed for chronic halitosis, marking a regulatory milestone for advanced oral care therapeutics.
- **Q4 2024: Johnson & Johnson Acquires BreathRx Brand to Strengthen Halitosis Portfolio** Johnson & Johnson completed the acquisition of the BreathRx brand, enhancing its portfolio of products targeting halitosis and oral malodor.
- **Q1 2025: LISTERINE Launches Advanced Formula for Bad Breath in Asia-Pacific** LISTERINE introduced an advanced mouthwash formula targeting bad breath in the Asia-Pacific region, aiming to capture growing demand for halitosis solutions.
- **Q1 2025: Oral Care Startup BreathWell Raises $15M Series A to Develop Halitosis Diagnostic Device** BreathWell, a health tech startup, secured $15 million in Series A funding to accelerate development of its non-invasive halitosis diagnostic device.
- **Q2 2025: Procter & Gamble Announces Strategic Partnership with Dental Chain for Halitosis Education** Procter & Gamble formed a strategic partnership with a major dental chain to launch a halitosis education and treatment initiative across multiple clinics.
- **Q2 2025: FreshBreath Technologies Files for IPO to Fund Halitosis Treatment Market Product Expansion** FreshBreath Technologies filed for an initial public offering, aiming to raise capital for expanding its halitosis treatment product line and global distribution.
- **Q3 2025: Dentek Unveils New Tongue Cleaner for Halitosis Prevention** Dentek launched a new tongue cleaner designed to help prevent halitosis, broadening its oral hygiene product offerings.
- **Q3 2025: Novartis Receives European Approval for Halitosis Treatment Market Tablet** Novartis received regulatory approval in Europe for its new tablet indicated for the treatment of halitosis, expanding its presence in the oral care therapeutics market.

## Report Scope

| MARKET SIZE 2024 | 4.89(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 5.405(USD Billion) |
| MARKET SIZE 2035 | 14.7(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.52% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Colgate-Palmolive (US), Procter & Gamble (US), Unilever (GB), Johnson & Johnson (US), GlaxoSmithKline (GB), Church & Dwight (US), Henkel (DE), Listerine (US), Oral-B (US) |
| Segments Covered | Indication, Diagnostic Tests, Drug Treatment, Region |
| Key Market Opportunities | Emergence of innovative oral care products targeting specific halitosis causes presents growth potential in the Halitosis Treatment Market. |
| Key Market Dynamics | Rising consumer awareness drives demand for innovative halitosis treatments, influencing market competition and product development. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Halitosis Treatment Market?**
A: The Halitosis Treatment Market was valued at 4.89 USD Billion in 2024.

**Q: What is the projected market size for the Halitosis Treatment Market by 2035?**
A: The market is projected to reach 14.7 USD Billion by 2035.

**Q: What is the expected CAGR for the Halitosis Treatment Market during the forecast period?**
A: The expected CAGR for the Halitosis Treatment Market from 2025 to 2035 is 10.52%.

**Q: Which companies are the key players in the Halitosis Treatment Market?**
A: Key players include Colgate-Palmolive, Procter & Gamble, Unilever, Johnson & Johnson, and GlaxoSmithKline.

**Q: What are the major segments of the Halitosis Treatment Market?**
A: Major segments include indication, diagnostic tests, and drug treatment.

**Q: How much is the Gastrointestinal segment valued at in 2024?**
A: The Gastrointestinal segment was valued at 1.22 USD Billion in 2024.

**Q: What is the projected value of the Halimeter diagnostic test segment by 2035?**
A: The Halimeter segment is projected to reach 2.4 USD Billion by 2035.

**Q: What is the valuation of the drug treatment segment in 2024?**
A: The drug treatment segment was valued at 2.39 USD Billion in 2024.

**Q: How does the projected growth of the Halitosis Treatment Market compare to its 2024 valuation?**
A: The market is expected to grow significantly from 4.89 USD Billion in 2024 to 14.7 USD Billion by 2035.

**Q: What are the expected values for the systemic indication segment by 2035?**
A: The systemic indication segment is projected to reach 2.94 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/halitosis-treatment-market-3758*